4.7 Review

Deep brain stimulation in neurological diseases and experimental models: From molecule to complex behavior

Journal

PROGRESS IN NEUROBIOLOGY
Volume 89, Issue 1, Pages 79-123

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.pneurobio.2009.06.003

Keywords

Deep brain stimulation; High-frequency stimulation; Basal ganglia; Subthalamic nucleus; Globus pallidus; Substantia nigra; Thalamus; Parkinson's disease; Dystonia; Tourette's syndrome; Essential tremor; Depression; Behavior; Electrophysiology; Neuronal activity; Motivation; Addiction; Nucleus accumbens; Obsessive-compulsive disorder

Categories

Funding

  1. Centre National de la Recherche Scientifique (CNRS)
  2. Universite de la Mediterranee
  3. European Community [QLK6-1999-02173]
  4. Agence Nationale pour la Recherche [ANR-05-NEUR-021, ANR-05-NEUR-013, ANR-JC05-48262]
  5. Action Concertee Incitative (ACI) program of the French Research Ministry [04 2 91, NIC0057]
  6. Fondation de France
  7. MILDT-InCa-INSERM
  8. FRC

Ask authors/readers for more resources

Deep brain stimulation (DBS) has proven to be capable of providing significant benefits for several neuropathologies. It is highly effective in reducing the motor symptoms of Parkinson's disease, essential tremor, and dystonia, and in alleviating chronic pain. Recently, also Tourette syndrome, obsessive-compulsive disorder and treatment-resistant depression have been treated by DES with encouraging results. However, despite these clinical achievements, the precise action mechanisms of DBS still need to be fully characterized. For this reason, several animal models of DBS have been developed, bringing new insights on the effects of this treatment at molecular and cellular level, and providing new evidence on its physiological and behavioral consequences. In parallel, physiological and imaging Studies in patients have contributed to better understanding DBS impact on the function of brain circuits. Here we review the clinical data and experimental work in vitro, ex vivo and in vivo (mostly arisen from studies on DBS of the subthalamic nucleus) in the treatment of PD, which led to the actual knowledge of DBS mechanisms, from molecular to complex behavioral levels. (C) 2009 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available